Submitted by: Submitted by justinbarnes12
Views: 10
Words: 708
Pages: 3
Category: Business and Industry
Date Submitted: 08/12/2015 02:22 AM
Travel Vaccines Market - Global Industry Analysis and
Forecast 2015 - 2021
Persistence Market Research
Travel Vaccines Market - Global Industry
Analysis and Forecast 2015 - 2021
Persistence Market Research
1
Travel Vaccines Market - Global Industry Analysis and
Forecast 2015 - 2021
Persistence Market Research Released New Market Report on “Travel Vaccines Market Global Industry Analysis and Forecast 2015 - 2021”.
Health related complications are greater in developing countries and rural areas because of dissimilarities
in sanitary conditions, available food and water bases. The immunization Practices Advisory Committee of
the Center for Disease Control and Prevention (CDC) mentions that travelers should be up-to-date on
routine immunizations, irrespective of travel plans. The target population for the travel vaccines market
include outbound travelers. The travel vaccines for the prevention of hepatitis A, hepatitis B, yellow fever,
tetanus, poliomyelitis, meningococcal disease, typhoid fever are manufactured by leading market players
namely Sanofi Pasteur, Merck, Novartis and GlaxoSmithKline. Among these aforementioned companies,
Sanofi Pasteur and GSK are the notable players in the travel vaccines market that accounts for
approximately 85% of total market. Recently in March 2014, Sanofi Pasteur, the vaccines segment of
Sanofi announced its long term strategic collaboration with SK Chemicals Company to develop
pneumococcal conjugate vaccine (PCV).
Request Full TOC: http://www.persistencemarketresearch.com/toc/5753
The driving factors for the growth of this market include increase in awareness about vaccine preventable
diseases and rise in global travel traffic. Moreover, innovation of novel vaccine technologies and
technological advancements towards molecular genetics is further boosting the growth of market in
coming years. However, requirement of expertise for the production of vaccines and unfavorable
healthcare funding towards vaccination could pose a...